Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability [NA]

View source ↗

Summary

Clinical trial status update for a study evaluating nebulised hypertonic saline to reduce respiratory exacerbations in neuromuscular disease or neurodisability;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebulised hypertonic saline (Hypertonic saline)

Snippet

Sponsor: Imperial College London | Conditions: Neuromuscular Diseases, Neurodevelopmental Disorders | NA | Status: NOT_YET_RECRUITING